SKIN LOGICS
SKIN LOGICS
Tirzepatide is a ground-breaking treatment for type 2 diabetes and obesity. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucose-like peptie-1 (GLP-1) receptor agonist. These peptides working together is what sets Tirzepatide apart from other medical weight loss treatments. By targeting GIP and GLP-1 receptors, the weight loss product enhances the body's natural ability to stabilize blood sugar levels and promotes significant and sustainable weight loss.
Tirzepatide is the active ingredient in commonly used diabetic medications such as Mounjaro and Zepbound. The GIP/GLP-1 peptide was approved by the Food and Drug Administration to be compounded in late 2023--making this product more accesible for patients treating obesity.
This peptide may offer an extra weight loss boost compared to GLP-1 receptor agonists because it mimics the GLP-1 and GIP hormones.
*Prices subject to market fluctuations
We are now offering interest-free monthly payments! Apply today!
We are currently taking appointments for Tirzepatide patients. Visit the "Online Booking" link to find our availability.
Copyright © 2016 Skin Logics - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.